CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tiotropium / olodaterol

Last Updated: October 9, 2018
Result type: Reports
Project Number: SR0436-000
Product Line: Common Drug Review

Generic Name: Tiotropium / olodaterol

Brand Name: Inspiolto Respimat

Manufacturer: Boehringer Ingelheim (Canada) Ltd.

Indications: Chronic Obstructive Pulmonary Disease (COPD)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: December 17, 2015

Recommendation Type: List with criteria/condition